Analysis of the influence of therapy and viral suppression on high-risk sexual behaviour and sexually transmitted infections among patients infected with human immunodeficiency virus in Taiwan

Clinical Microbiology and Infection

Volumn 12, Issue 7, 2006, Pages 660-665

  Chen, S C ^a,b   Wang, S T ^c   Chen, K T ^c   Yan, T R ^a   Tang, L H ^d   Lin, C C ^e   Yen, S F ^e  

^a TATUNG UNIVERSITY   (Taiwan)

^b Zhongxiao Branch   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^d CENTER FOR DISEASE CONTROL   (Taiwan)

^e Taipei City STD Control Center   (Taiwan)

Author keywords

AIDS; Human immunodeficiency virus; Risk factors; Sexual behaviour; Sexually transmitted disease; Transmission

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PATIENT EDUCATION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SEX DIFFERENCE; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE; SEXUALLY TRANSMITTED DISEASE; TAIWAN; UNSAFE SEX; VIRUS INHIBITION; VIRUS STRAIN; VIRUS TRANSMISSION;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 33744917299     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2006.01473.x     Document Type: Article

References (20)

1. Tassie JM, Grabar S, Lancar R, Deloumeaux J, Bentata M, Costagliola D. Time to AIDS from 1992 to 1999 in HIV-1 infected subjects with known date of infection. J AIDS 1992; 30: 81-87.
2. Quinn TC, Wawer MJ, Sewankambo N et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 2000; 342: 921-929.
3. Mofenson LM, Lambert JS, Stiehm ER et al. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team. N Engl J Med 1999; 341: 385-393.
4. Garnett GP, Bartley L, Grassly NC, Anderson RM. Antiretroviral therapy to treat and prevent HIV/AIDS in resource-poor settings. Nat Med 2002; 8: 651-654.
5. Hosseinipour M, Cohen MS, Vernazza PL, Kashuba AD. Can antiretroviral therapy be used to prevent sexual transmission of human immunodeficiency virus type 1? Clin Infect Dis 2002; 34: 1391-1395.
6. Anonymous. Health and vital statistics. I. General health statistics. Taipei: Department of Health, Taiwan, 2002.
7. Twu SJ, Huang YF, Lai AC, Ou NM, Su IJ. Update and projection on HIV/ AIDS in Taiwan. AIDS Edu Prevent 2004; 16: 53-63.
8. McGowan JP, Shah SS, Ganea CE et al. Risk behaviour for transmission of human immunodeficiency virus (HIV) among HIV-seropositive individuals in an urban setting. Clin Infect Dis 2004; 38: 122-127.
9. Centers for Disease Control and Prevention. Increases in HIV diagnoses - 29 states, 1999-2002. MMWR 2003; 52: 1145-1148.
10. Cox J, Beauchemin J, Allard R. HIV status of sexual partners is more important than antiretroviral treatment related perceptions for risk taking by HIV positive MSM in Montreal, Canada. Can Sex Transm Infect 2004; 80: 518-523.
11. Van de Ven P, Prestage G, Crawford J, Grulich AE, Kippax S. Sexual risk behaviour increases and is associated with HIV optimism among HIV-negative and HIV-positive gay men in Sydney over the 4 year period to February 2000. AIDS 2000; 14: 2951-2953.
12. Erbelding EJ, Stanton D, Quinn TC, Rompalo A. Behavioral and biologic evidence of persistent high-risk behaviour in an HIV primary care population. AIDS 2000; 14: 297-301.
13. van der Snoek EM, de Wit JB, Mulder PG, van der Meijden WI. Incidence of sexually transmitted diseases and HIV infection related to perceived HIV/ AIDS threat since highly active antiretroviral therapy availability in men who have sex with men. Sex Transm Dis 2005; 32: 170-175.
14. Katz MH, Schwarcz SK, Kellogg TA et al. Impact of highly active antiretroviral treatment on HIV seroincidence among men who have sex with men: San Francisco. Am J Public Health 2002; 92: 388-394.
15. Wolf K, Young J, Rickenbach M et al. Prevalence of unsafe sexual behaviour among HIV-infected individuals: The Swiss HIV Cohort study. J AIDS 2003; 33: 494-499.
16. Scheer S, Chu PL, Klausner JD, Katz MH, Schwarcz SK. Effect of highly active antiretroviral therapy on diagnosis of sexually transmitted diseases in people with AIDS. Lancet 2001; 357: 432-435.
17. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: The contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 1999; 75: 3-17.
18. Robertson JR, Bucknall AB, Welsby PD et al. Epidemic of AIDS related virus (HTLV-III/LAV) infection among intravenous drug abusers. BMJ 1986; 292: 527-529.
19. Angarano G, Pastore G, Monno L, Santantonio T, Luchena N, Schiraldi O. Rapid spread of HTLV-III infection among drug addicts in Italy. Lancet 1985; 2: 1302.
20. Weidle PJ, Ganea CE, Irwin KL et al. Adherence to antiretroviral medications in an inner-city population. J AIDS 1999; 22: 498-502.